Drug Shortage Report for FASTURTEC

Last updated on 2023-09-19 History
Report ID 193234
Drug Identification Number 02248416
Brand name FASTURTEC
Common or Proper name FASTURTEC
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) RASBURICASE
Strength(s) 1.5MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 3 vials
ATC code V03AF
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2023-05-26
Actual start date 2023-05-25
Estimated end date 2023-09-29
Actual end date
Shortage status Actual shortage
Updated date 2023-09-19
Company comments Health Canada has allowed the temporary importation and distribution of Great Britain –labelled product to manage this shortage. Due to the limited inventory available there will be some order restrictions. Lot No. 3J1011, Expiry Date:28.02.2026, PLGB 04425/0821 Please contact LAVALCS@sanofi.com in case of questions.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2023-05-26 English Compare
v2 2023-05-26 French Compare
v3 2023-06-09 English Compare
v4 2023-06-09 French Compare
v5 2023-06-09 English Compare
v6 2023-06-09 French Compare
v7 2023-07-21 English Compare
v8 2023-07-21 French Compare
v9 2023-09-19 English Compare
v10 2023-09-19 French Compare

Showing 1 to 10 of 10